“Simulating a clinical trial before running it is cutting real trial failure rates.”

Pharmaceutical companies are increasingly using biosimulation to predict trial outcomes and optimize dosing before committing to expensive human trials, a shift that's accelerating as the simulation models themselves get more reliable.